What led to the discovery of novel antibiotic structural classes (i.e., norcardicins, carbapenems, and monobactams).

The production of bacterial strains supersensitive to B-lactams, tests for the inhibition of B-lactamases, and specificity for sulfur-containing metabolites in the 1970s.